Emmanuel Weyl

Emmanuel Weyl is an experienced professional in the pharmaceutical industry, specializing in business development for RNA therapeutics. With a background in biotechnology and biomedical sciences, Weyl has held various roles in companies like Dexcel Pharma and Compugen, where Emmanuel focused on identifying licensing opportunities and establishing partnerships in oncology. With a strong educational background including an MBA in Finance and Strategy, Weyl has proven expertise in commercial assessments and promoting technology and drug projects to prospective partners.